The experts you need.
Our founding partners lead a talented team of diverse and experienced consultants, drawn from political, healthcare and communications backgrounds.
Bill is one of the country’s leading experts on health policy and politics, and has advised national politicians, multinationals, regulators, small-and-medium sized companies, providers and charities on the ways to effect change in healthcare systems across the world. He is a former Special Adviser at the UK Department of Health, and has twice been named one of the 100 most influential people in the NHS.
Sarah has nearly two decades of experience in health policy consultancy, creating and leading high profile international and national programmes for pharmaceutical clients, charities and campaigning coalitions. Prior to her consultancy career, she helped establish and ultimately led Cancer Research UK’s parliamentary function, helping the charity secure important policy wins on tobacco control policy and the funding of cancer services.
Mike is an expert in driving policy change in health and care in many different health systems. He has been responsible for award-winning campaigns, leading to significant wins for patients on issues such as earlier and more accurate diagnosis, access to new treatments and improvements in the organisation and delivery of services. He writes for the Health Service Journal and has been awarded the Communiquétor of the Year award.
Mike is former Chief Inspector of Hospitals and one of the most widely respected clinical leaders in the NHS. He served in a variety of senior clinical roles at NHS England and the Department of Health, including the National Clinical Director for Cancer. He has been responsible for developing clinical strategies on cancer, end of life care and cardiovascular disease, in addition to being instrumental in delivering reforms to access to medicines.
Acting Head of Brussels
Aurélie has worked in European and national Public Affairs for the past decade. She combined agency and in-house experience in Paris, Washington D.C and Brussels. She has extensive expertise in helping organisations to design their EU affairs strategies. Aurelie has worked closely with small biotech companies and large pharma companies on advocacy programmes. Aurélie holds a Master degree in European Affairs.
Richard is the former Director General for Finance, Strategy and the NHS at the Department of Health. He retired from the civil service as Whitehall’s longest-serving finance director, having been Whitehall’s youngest ever Director General when appointed. One of the most influential civil servants in the NHS’s history, he is widely respected in 10 Downing Street, HM Treasury and across government for his track record in controlling the £100 billion NHS budget for well over a decade.
Ed has extensive experience of helping clients to understand and overcome market access challenges, with a particular focus on rare diseases. Ed leads Incisive Health’s work with clients seeking to shape the NHS’s approach to advanced therapy medicinal products and has a track record of delivering policy change to support enhanced patient access to highly innovative treatments. Prior to joining Incisive Health, Ed worked in-house at a major pharmaceutical company.
During her career in health policy, Elizabeth has worked at the intersection of the third sector, industry and the NHS, advising clients on the facilitation of partnership working and collaborative approaches for addressing complex health policy questions. She enjoys the challenge of campaigning on issues often ignored because of rarity or social taboos and working with clients to find a distinct, authentic voice with which to communicate.
Jonny has extensive experience supporting clients to achieve their goals, having worked in healthcare consultancy since 2012. His work with a range of providers, charities, trade associations and pharmaceutical companies has helped to drive change, including in public health, primary care and social care. Jonny co-led the healthcare team at another consultancy, prior to which he gained experience in Parliament and local government.
Kieran has extensive experience in public affairs and campaigning. Since joining Incisive Health in 2016, he has led programmes for many of the world’s largest pharmaceutical companies, as well as providers, charities and campaigning coalitions. Kieran has particular expertise in access and reimbursement policy. He holds a degree in History from the University of Oxford and a Masters from King’s College London.
Louise brings extensive experience from public, consultancy and industry roles in the UK and abroad. Most recently, she held roles across the Asia Pacific Region leading strategies for access to precision medicine and better outcomes in cancer and rare diseases. She has specific expertise in global policy and access strategy, patient advocacy and policy skill building that she brings to our international clients.
Toby has worked in life sciences public affairs since 2013. He has extensive experience of delivering effective campaigns on diagnostics, genomics, health tech and medical devices, with a particular focus on the treatment and management of diabetes, stroke and HIV. Toby has a particular interest in how the potential of technology can be utilised across the NHS. Toby previously worked for George Freeman MP, supporting him in his role of Government Life Sciences Advisor.
Claire has 13 years’ experience working in the health and life sciences sectors. She joined Incisive Health from The Institute of Cancer Research, where she was Head of Media Relations, giving her extensive expertise in raising public and political awareness of key policy issues to drive change. Claire is the former Chair of the STEM PR Association and has a PhD from University College London.
Gianluca has extensive experience creating and leading communication campaigns on diagnostics, health tech and medical devices, with a focus on the value of medical technologies. Gianluca has a particular interest in how communication and PR can improve people’s understanding of healthcare and technology. Prior to joining Incisive Health, Gianluca worked as a communications manager for MedTech Europe, the European Trade Association for Medical Technology.
Laura joined Incisive Health in 2018 from a governance consultancy, where she worked primarily with the health and social care sector. Laura has experience working with pharmaceutical and third sector clients in a wide range of areas including women’s health, oncology and public health and prevention. She has a particular interest in the NHS landscape and ongoing journey to integrated care.
Oliver has worked as a consultant at Incisive Health since 2016. During this time, he has worked on a number of medicines access issues, with a particular focus on personalised and advanced therapies, such as gene therapy. Additionally, he has an interest in Brexit-related issues facing pharmaceutical clients and above-brand corporate strategy.
Claire joined Incisive Health in early 2019, having previously worked at the European Commission’s Directorate General for International Cooperation and Development. She holds a Master’s degree in International Relations from the University of Manchester. Claire supports clients across a range of health issues with a particular focus on oncology. She is fluent in English, French, Italian and Spanish and also speaks Portuguese.
At Incisive Health, David works with large pharmaceutical clients as well as national and international charities to support their political engagement, public affairs and communications activity. David has previously worked for an MP, within the communications team at a local authority, as well as another public affairs agency where he developed his health and social care expertise.
Giulia brings extensive expertise in healthcare policy and EU public affairs, following five years at the European Healthcare Distribution Association. She advises clients on a variety of topics, from multi-stakeholder advocacy initiatives to rare diseases and building public affairs capabilities. Giulia is fluent in Italian, English, German and Spanish, and also speaks French. She is also actively engaged in the European Health Parliament.
Henry joined Incisive Health after completing an MA in Governance and Public Policy, having previously been awarded First Class Honours with Distinction for his BA in Politics with International Relations. Prior to joining Incisive Health, Henry had written on global health for an academic journal and he now advises clients on a range of issues including corporate strategy, NICE reform and care for people with long-term health conditions.
Riddhi joined Incisive Health through the internship programme in 2018. She completed her undergraduate degree in Global Health at Queen Mary, University of London, graduating at the top of her class with a First. Riddhi works with clients across a range of health issues from liver disease to corporate strategy and has a particular interest in non-communicable diseases, health inequalities and public health interventions.
Cat joined Incisive Health in 2020, following a year working in the Government Affairs and External Communications team of a global pharmaceutical company. Cat provides policy and communications support to clients across a range of health issues such as rare diseases, women’s health and influenza. She holds a Master’s degree in Genetics from the University of Aberdeen and is fluent in English, Portuguese, Italian and Spanish.
Toby has worked as a consultant in healthcare communications since 2018, delivering a number of high-impact policy advocacy campaigns across a range of therapy areas. Toby has extensive experience of working within Westminster, advising clients on public affairs and engagement strategy to help drive innovation within the ever-changing NHS landscape.
Emilie joined Incisive Health as an Account Manager in October 2020 from the European Society for Medical Oncology (ESMO). She has first-hand knowledge of the European institutions having been the healthcare advisor for a Member of the European Parliament. She holds a BA and a MA in European Studies from Maastricht University. She is fluent in Dutch and English, and also speaks some Spanish and German.
Anna provides policy and public affairs support to several of Incisive Health’s pharmaceutical clients, drawing on her past experience of working for a Member of Parliament, to provide advice on effective political engagement and communications. Anna joined Incisive Health from the Portman Group where she supported political and corporate stakeholder engagement projects.
James joined Incisive Health as an Account Executive in April 2020, having previously worked at another London-based consultancy specialising in healthcare policy. Before moving into consultancy, James gained experience in Parliament working for a Labour and Co-operative MP. At Incisive, James supports clients across a wide range of areas with a particular interest in public and preventative health. He holds a bachelor’s degree in Politics.
Isabella joined Incisive Health from another Brussels and London-based consultancy where she focused on EU health and food policy and Italian politics. She holds a Master of Arts in Politics and International Relations from the University of Aberdeen. She is fluent in Italian and English and can also speak some French.
Thomas Bolton King
Tom works for a range of clients specialising in areas such as genomics, ophthalmology and digital healthcare services. Prior to joining Incisive Health, Tom worked with another public affairs consultancy, as well as supporting the Liberal Democrat 2019 election campaign. He holds a BA History from the University of Sussex and a further MA in Politics and Contemporary History from King’s College London.
Eduardo has contributed to advancing public policy discussions from a close vantage point, having over three decades of international experience in leadership roles for global healthcare companies and associations, also in the non-profit sector, mainly in Brussels and Geneva. Currently, he leads a global non-profit multi-stakeholder organization focusing on cancer care efficiency, and collaborates with a digital health start-up with a social impact mission operating in low- and middle-income countries.